We have located links that may give you full text access.
Association Between Initiation of Pulmonary Rehabilitation and Rehospitalizations in Patients Hospitalized with COPD.
RATIONALE: Althoughl clinical trials have found that pulmonary rehabilitation (PR) can reduce the risk of readmissions following hospitalization for a COPD exacerbation, less is known about PR's impact in routine clinical practice.
OBJECTIVE: We evaluated the association between initiation of PR within 90 days of discharge and rehospitalization(s).
METHODS: We analyzed a retrospective cohort of Medicare beneficiaries (≥ 66 years) hospitalized for COPD in 2014 who survived at least 30 days following discharge.
MEASUREMENTS: We used propensity score (PS) matching and estimated the risk of recurrent all-cause rehospitalizations at one year using a multi-state model to account for the competing risk of death.
MAIN RESULTS: Of 197,376 patients hospitalized in 4,446 hospitals, 2,721 patients (1.5%) initiated PR within 90 days of discharge. Overall, 1,534 (56.4%) of patients who initiated PR and 125,720 (64.6%) who did not were rehospitalized one or more times within one year of discharge. In the PS matched analysis, PR initiation was associated with a lower risk of readmission in the year following PR initiation (Hazard Ratio: 0.83; 95% CI: 0.77 - 0.90). The mean cumulative number of rehospitalizations at one year was 0.95 for those who initiated PR within 90 days and 1.15 for those who did not (p<0.001).
CONCLUSIONS: After hospitalization for COPD, Medicare beneficiaries who initiated PR within 90 days of discharge experienced fewer rehospitalizations over one year. These results support findings from randomized clinical trials and highlight the need to identify effective strategies to increase PR participation. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/).
OBJECTIVE: We evaluated the association between initiation of PR within 90 days of discharge and rehospitalization(s).
METHODS: We analyzed a retrospective cohort of Medicare beneficiaries (≥ 66 years) hospitalized for COPD in 2014 who survived at least 30 days following discharge.
MEASUREMENTS: We used propensity score (PS) matching and estimated the risk of recurrent all-cause rehospitalizations at one year using a multi-state model to account for the competing risk of death.
MAIN RESULTS: Of 197,376 patients hospitalized in 4,446 hospitals, 2,721 patients (1.5%) initiated PR within 90 days of discharge. Overall, 1,534 (56.4%) of patients who initiated PR and 125,720 (64.6%) who did not were rehospitalized one or more times within one year of discharge. In the PS matched analysis, PR initiation was associated with a lower risk of readmission in the year following PR initiation (Hazard Ratio: 0.83; 95% CI: 0.77 - 0.90). The mean cumulative number of rehospitalizations at one year was 0.95 for those who initiated PR within 90 days and 1.15 for those who did not (p<0.001).
CONCLUSIONS: After hospitalization for COPD, Medicare beneficiaries who initiated PR within 90 days of discharge experienced fewer rehospitalizations over one year. These results support findings from randomized clinical trials and highlight the need to identify effective strategies to increase PR participation. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app